Answer
The most frequently reported adverse reactions in adults receiving rilpivirine and cabotegravir injections were injection site reactions, headache and pyrexia (fever).
Sources for this answer
- Rekambys 900 mg prolonged-release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.8 Undesirable effects · Version 10Document updated
Sources checked